REGENERON PHARMACEUTICALS

Regeneron insider trades show EVP Joseph Larosa buying low and selling near market highs, hinting at confidence in long‑term prospects while securing liquidity for potential strategic moves.

Regeneron CFO Fenimore’s recent buy‑sell trade shows routine portfolio balancing, not a red flag, as the company’s solid pipeline and $81B market cap continue to support investor confidence.